Thymosin Alpha-1
Immunomodulatory peptide studied for T-cell maturation and immune resilience.
Recon & Dosing
Open the calculator for Thymosin Alpha-1 vials.
- Category
- Longevity
- Half-life
- ~2 hours
- Typical vial
- 5 mg / 10 mg lyophilised
- Reported research dose
- 1.6 mg twice weekly in clinical arms
Mechanism of action
Enhances dendritic and T-cell function via Toll-like receptor signalling.
Storage & handling
Refrigerate; reconstituted stability approximately 28 days.
Run the reconstitution math →Research notes
- Approved for hepatitis indications in several countries.
Research use only. Figures above summarise published literature and community protocols for reference. Nothing here is a recommendation for human use.